有症状与无症状心房颤动的临床结局:一项荟萃分析
频繁主义分析显示,有症状患者新发心力衰竭风险增加33%,进展为永久性房颤风险降低30%,但全因死亡、心血管死亡、血栓栓塞、卒中、住院和心肌梗死风险无显著差异。贝叶斯分析结果类似,但新发心力衰竭关联不显著。
要点
- 有症状与无症状房颤患者的主要临床结局风险无显著差异。
- 有症状患者新发心力衰竭风险增加33%,但贝叶斯分析不显著。
- 无症状患者进展为永久性房颤的风险更高。
核心结论
- 有症状与无症状房颤患者的主要临床结局风险无显著差异。
- 无症状患者进展为永久性房颤的风险更高。
主要发现
- 有症状患者接受抗心律失常药物(OR 1.64,95%CI 1.33-2.03)和消融治疗(OR 1.47,95%CI 1.06-2.05)的几率更高。
临床怎么用
- 房颤患者症状状态不应作为判断主要临床结局风险的主要依据。
- 无症状房颤患者需关注永久性房颤进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current guidelines suggest that asymptomatic atrial fibrillation (AF) is independently associated with increased risks of stroke and mortality compared with symptomatic AF. Considering that recent investigations have provided conflicting results, the present study aimed to evaluate the association between symptom status and clinical outcomes in patients with AF. METHODS: Medline, Cochrane Library, and Scopus were searched until 25 March 2024. Triple-independent study selection, data extraction and quality assessment were performed. Evidence was pooled using random-effects meta-analyses. RESULTS: Thirty-six studies (217 850 participants) were included. Based on the frequentist analysis, symptomatic individuals had no significant difference in the risk of all-cause mortality [hazard ratio (HR) .97, 95% confidence interval (CI) .80-1.17], cardiovascular mortality (HR 1.04, 95% CI .72-1.49), thromboembolism (HR 1.06, 95% CI .87-1.28), stroke (HR 1.06, 95% CI .84-1.34), hospitalization (HR 1.34, 95% CI .89-2.02), and myocardial infarction (HR .98, 95% CI .70-1.36), compared to the asymptomatic group. Symptomatic patients had a 33% increased risk of new-onset heart failure (HR 1.33, 95% CI 1.19-1.49) and a 30% lower risk of progression to permanent AF (HR .70, 95% CI .54-.89). The Bayesian analysis yielded comparable results, yet the association between symptom status and new-onset heart failure was not significant (HR 1.27, 95% credible interval .76-1.93; Bayes factor = 1.2). Symptomatic patients had higher odds of receiving antiarrhythmic drugs (odds ratio [OR] 1.64, 95% CI 1.33-2.03) and ablation therapy (OR 1.47, 95% CI 1.06-2.05) compared to asymptomatic cases. CONCLUSIONS: The risk of major clinical outcomes did not differ between individuals with and without AF-related symptoms. Asymptomatic patients had a greater hazard of progression to permanent AF.
引用
- Karakasis, Pamporis, Siontis, et al. Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis. Eur Heart J. 2025. PMID: 39428997. doi:10.1093/eurheartj/ehae694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。